Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BICD cargo adaptor 1 pseudogene 1 (BICD1P1) is classified as a **pseudogene**—that is, a genomic DNA sequence similar to a functional gene but typically non-functional due to mutations or the absence of regulatory elements. As a pseudogene, BICD1P1 does not encode an active protein product, nor is it implicated as a receptor, enzyme, transporter, or other therapeutic target. There are no known biological functions, disease associations, or mechanisms of action attributed to this locus. Its name refers to its homology with the functional BICD cargo adaptor 1 gene (BICD1), but the pseudogene itself is not known to be involved in cellular processes or human disease[4]. **There appears to be confusion in some resources between BICD1 (a functional protein) and BICD1P1 (a non-coding pseudogene). BICD1P1 should not be considered a therapeutic target.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BICD cargo adaptor 1 pseudogene 1 (BICD1P1).